/

Kyverna Therapeutics

Developing cell therapies for patients with autoimmune diseases.

BiotechnologyPharmaceuticals kyvernatx.com ↗

Company facts

Founded: 2018
Employees: 153
Headquarters: United States
Type: Public
Listed: NASDAQ: KYTX